Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Fairview Ridges Hospital
Burnsville, Minnesota, United States
- Mercy and Unity Cancer Center at Mercy Hospital
Coon Rapids, Minnesota, United States
- Fairview Southdale Hospital
Edina, Minnesota, United States
- Mercy and Unity Cancer Center at Unity Hospital
Fridley, Minnesota, United States
- Minnesota Oncology Hematology, Pa - Maplewood
Maplewood, Minnesota, United States
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
Minneapolis, Minnesota, United States
- Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
Robbinsdale, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Park Nicollet Cancer Center
Saint Louis Park, Minnesota, United States
- United Hospital
Saint Paul, Minnesota, United States
- Ridgeview Medical Center
Waconia, Minnesota, United States
- Minnesota Oncology Hematology, Pa - Woodbury
Woodbury, Minnesota, United States
- Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Jan 2004
- Primary completion
- 30 Sept 2007
- Completion
- 31 Mar 2011
- Last update posted
- 18 Jun 2023
- Registered enrollment
- 8
- Registry id
- NCT00052884
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.